Tag Archives: diagnostics

Europe: New Device and Diagnostics Legislation Could Shake Up the Drug Industry

EuropeNew Device and Diagnostics Legislation Will Shake Up Drug Industry The shockwaves from the current European Union debates in Brussels on medical devices are are likely to echo through the medicines business over the next few years. This month, the European parliament’s health committee will reach its view on the two major proposals launched last […]
Posted in Europe, Op-Ed, Regulatory | Also tagged , , , | 1 Comment

Roche Ups the Stakes on Personalized Medicine

By Patricia Van Arnum, Pharmaceutical Technology. Personalized medicine, which targets individualized treatment and care based on personal and genetic variations, holds much promise for the pharmaceutical industry. Several pharmaceutical majors continue to invest in this emerging field as evident by Roche’s $5.7-billion bid last week for Illumina, a provider of gene-sequencing tools and related analytics.
Posted in Biotech, Europe, Global, Guest Blog | Also tagged , | 1 Comment

Cancer Testing Times: One Thing the UK Will Not Be Cutting

Buried among the savage, £83 billion-worth of cuts announced by the UK coalition government’s controversial Comprehensive Spending Review last week was confirmation that the Department of Health would not be taking forward the previous government’s pledge to introduce a one-week target for cancer testing. Under the Labour government, the time that it took for a […]
Posted in Europe, Global, Guest Blog | Also tagged , , , | Leave a comment

A Few Words About Diversification

Guest blog by Dr Brian White, an analyst at Shore Capital. As a result of the feared impact of the patent expiry cliff, the decimation of branded sales by multi-sourced generics and the obstacles erected, especially by managed care in the US, to slow the uptake of branded pharmaceuticals where a generic in the same […]
Posted in Europe, Global, Guest Blog, Strategy | Also tagged , , , , , | Leave a comment
  • Categories

  • Meta